Samuel Samnick

Dec 27, 2023 | mdpi.com | Andreas Bück |Samuel Samnick |Gabriele Riehl

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Jun 30, 2023 | jnm.snmjournals.org | Andreas Bück |Sebastian E. Serfling |Sabrina Kraus |Samuel Samnick

Leukemia and LymphomaPatients with AML may benefit from CXCR4-directed molecular imaging because of the origin of this disease in the protective BM niche, along with the antileukemia effects of CXCR4 antagonists (56,57). Herhaus et al. first investigated the primary blasts of patients and reported on an association of blast counts with CXCR4 upregulation using flow cytometry.